Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） [Phase 1, Phase 2]
Phase 1/2 trial evaluating tolerability, pharmacokinetics, and preliminary efficacy of ZSP1603 in idiopathic pulmonary fibrosis has complete…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study
A completed prospective study investigating molecular diagnosis for idiopathic interstitial pneumonias.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
This update reports the completion of a clinical trial validating a risk stratification score for idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating long-acting octreotide for idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 clinical trial update indicating completion of a study evaluating 18F-FMISO PET hypoxia imaging in idiopathic pulmonary fibrosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib [Phase 1]
A Phase 1 study assessing safety, tolerability, and blood levels of GSK3915393 in healthy participants of Chinese, Japanese, and European an…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT [EARLY_Phase 1]
An early-phase study update on detecting integrin αvβ6 with PET/CT in patients with idiopathic pulmonary fibrosis, primary sclerosing cholan…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects [Phase 1]
Vicore Pharma AB's first-in-human Phase 1 study of C106 in healthy subjects assessed safety, tolerability, and pharmacokinetics; results hav…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial results report safety, pharmacokinetics, and pharmacodynamics of garadacimab in idiopathic pulmonary fibrosis. The study is co…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating jaktinib hydrochloride tablets in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Quality of Life in IPF - Patient and Physician Perceptions
A completed clinical trial evaluating quality of life in Idiopathic Pulmonary Fibrosis. The study assesses patient and physician perceptions…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: GKT137831 in IPF Patients with Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial of GKT137831 in idiopathic pulmonary fibrosis has completed, per the update from the University of Alabama at Birmingham.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: 23andMe IPF Research Study
This is a clinical trial update for the 23andMe IPF research study. The study on idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial evaluating ENV-101 for idiopathic pulmonary fibrosis has completed, with an update on safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetic study of SC1011 in healthy subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: The First-in-human Study of SRN-001 in Healthy Participants [Phase 1]
This report communicates completion of a first-in-human Phase 1 study of SRN-001 in healthy participants to evaluate safety and tolerability…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis
A completed clinical trial directly comparing pirfenidone and nintedanib for efficacy in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: All-Case Surveillance of Ofev in Patients With IPF in Japan
Completed all-case surveillance study of Ofev (nintedanib) in Japanese patients with idiopathic pulmonary fibrosis; results were posted in O…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients
A completed clinical trial evaluates the burden of non-adherence to nintedanib in patients with idiopathic pulmonary fibrosis. Results have …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
Phase 3 Zephyrus I trial evaluating pamrevlumab for idiopathic pulmonary fibrosis has been terminated, and results have been posted on clini…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions [Phase 1]
A Phase 1 pharmacokinetic study comparing pirfenidone modified-release tablets to standard pirfenidone tablets in healthy volunteers under f…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
This clinical trial update notes the completion of a study characterizing apolipoprotein A-I pathways in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions [Phase 1]
Phase 1 study comparing pharmacokinetics of pirfenidone modified-release tablets with standard pirfenidone tablets in healthy subjects under…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)
This clinical trial update reports the completion of a study using laser-induced breakdown spectroscopy to image elemental composition in lu…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis
This post-marketing surveillance study from Boehringer Ingelheim evaluates nintedanib in Indian patients with idiopathic pulmonary fibrosis,…